Gene tech firm seeks Aim float
Horizon Discovery has become the latest research group to seek funding on the London stock markets after announcing a float to raise £25m on Aim. The Cambridge-based company, which produces “patients in a test tube”, or human gene chains that can be used for medical research, said the cash will help find new customers for the tools and pay for additional research and development. Panmure Gordon is advising on the float.